Consequently, this results in increased MDM2-mediated ubiquitination of p53 in the cytoplasm, thereby promoting p53 protein degradation and ultimately leading to the development of hepatocellular carcinoma (HCC). The gene discussed is MDM2; the disease is hepatocellular carcinoma.